Arcus Biosciences, Inc.RCUSNYSE
Loading
EBITDA as a percentage of revenue
Latest
-135.63%
↑ 78% vs avg
Percentile
P75
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-623.16%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -135.63% | -30.1% |
| 2024 | -104.26% | +58.1% |
| 2023 | -248.72% | -8.0% |
| 2022 | -230.36% | -1595.4% |
| 2021 | 15.40% | +110.0% |
| 2020 | -153.85% | +71.6% |
| 2019 | -540.88% | +11.7% |
| 2018 | -612.89% | +83.0% |
| 2017 | -3597.24% | - |